---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-24-000076"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:34:51.791529+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# Recursion annual meeting elects Class III directors, approves say-on-pay

## Summary
- Blake Borgeson, Ph.D. elected as Class III director with 165,914,956 votes for, 26,093,759 withheld.
- Dean Y. Li, M.D., Ph.D. elected as Class III director with 166,211,058 votes for, 25,797,657 withheld.
- Advisory resolution on executive compensation approved with 188,317,831 for, 2,887,180 against, 803,704 abstentions.

## SEC filing metadata
- accession: 0001601830-24-000076
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183024000076/0001601830-24-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183024000076/rxrx-20240603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-24-000076
- JSON: https://secwatch.observer/filing/0001601830-24-000076.json
- Plain text: https://secwatch.observer/filing/0001601830-24-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.